Recent evidence supports the concept that progression of chronic heart failure (CHF) depends upon an imbalance of catabolic forces over the anabolic drive. In this regard, multiple hormonal deficiency syndrome (MHDS) significantly has impacts upon CHF progression, and is associated with a worse clinical status and increased mortality. The T.O.S.CA. (Trattamento Ormonale nello Scompenso CArdiaco; Hormone Therapy in Heart Failure) Registry (clinicaltrial.gov = NCT02335801) tests the hypothesis that anabolic deficiencies reduce survival in a large population of mild-to-moderate CHF patients. The T.O.S.CA. Registry is a prospective multicenter observational study coordinated by "Federico II" University of Naples, and involves 19 centers situated throughout Italy. Thyroid hormones, insulin-like growth factor-1, total testosterone, dehydroepiandrosterone , and insulin are measured at baseline and every year for a patient-average follow-up of 3 years. Subjects with CHF are divided into two groups: patients with one or no anabolic deficiency, and patients with two or more anabolic deficiencies at baseline. The primary endpoint is the composite of all-cause mortality and cardiovascular hospitalization. Secondary endpoints include the composite of all-cause mortality and hospitalization, the composite of cardiovascular mortality and cardiovascular hospitalization, and change of VO2 peak. Patient enrollment started in April 2013, and was completed in July 2017. Demographics and main clinical characteristics of enrolled patients are provided in this article. Detailed cross-sectional results will be available in late 2018. The T.O.S.CA. Registry represents the most robust prospective observational trial on MHDS in the field of CHF. The study findings will advance our knowledge with regard to the intimate mechanisms of CHF progression and hopefully pave the way for future randomized clinical trials of single or multiple hormonal replacement therapies in CHF.

Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry / Bossone, E.; Arcopinto, M.; Iacoviello, M.; Triggiani, V.; Cacciatore, F.; Maiello, C.; Limongelli, G.; Masarone, D.; Perticone, F.; Sciacqua, A.; Perrone-Filardi, P.; Mancini, A.; Volterrani, M.; Vriz, O.; Castello, R.; Passantino, A.; Campo, M.; Modesti, P.A.; De Giorgi, A.; Monte, I.; Puzzo, A.; Ballotta, A.; Caliendo, L.; D’Assante, R.; Marra, A.M.; Salzano, A.; Suzuki, T.; Cittadini, A.; Saccà, L.; Monti, M.G.; Napoli, R.; Matarazzo, M.; Stagnaro, F.M.; Schiavo, A.; Valente, P.; Ferrara, F.; Russo, V.; Malinconico, M.; Citro, R.; Guastalamacchia, E.; Leone, M.; Amarelli, C.; Mattucci, I.; Calabrò, P.; Calabrò, R.; D’Andrea, A.; Maddaloni, V.; Pacileo, G.; Scarafile, R.; Belfiore, A.; Cimellaro, A.; Perrone Filardi, P.; Casaretti, L.; Paolillo, S.; Gargiulo, P.; Favuzzi, A.M.R.; Di Segni, C.; Bruno, C.; Vergani, E.; Massaro, R.; Grimaldi, F.; Frigo, A.; Sorrentino, M.R.; Malandrino, D.; Manfredini, R.; De Giorgi, A.; Fabbian, F.; Ragusa, L.; Carbone, L.; Frigiola, A.; Generali, T.; Giacomazzi, F.; De Vincentiis, C.; Garofalo, P.; Malizia, G.; Milano, S.; Misiano, G.; Heaney, L.M.; Bruzzese, D.. - In: INTERNAL AND EMERGENCY MEDICINE. - ISSN 1828-0447. - STAMPA. - 13:(2018), pp. 661-671. [10.1007/s11739-018-1844-8]

Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry

Modesti, P. A.
Conceptualization
;
Malandrino, D.
Membro del Collaboration Group
;
2018

Abstract

Recent evidence supports the concept that progression of chronic heart failure (CHF) depends upon an imbalance of catabolic forces over the anabolic drive. In this regard, multiple hormonal deficiency syndrome (MHDS) significantly has impacts upon CHF progression, and is associated with a worse clinical status and increased mortality. The T.O.S.CA. (Trattamento Ormonale nello Scompenso CArdiaco; Hormone Therapy in Heart Failure) Registry (clinicaltrial.gov = NCT02335801) tests the hypothesis that anabolic deficiencies reduce survival in a large population of mild-to-moderate CHF patients. The T.O.S.CA. Registry is a prospective multicenter observational study coordinated by "Federico II" University of Naples, and involves 19 centers situated throughout Italy. Thyroid hormones, insulin-like growth factor-1, total testosterone, dehydroepiandrosterone , and insulin are measured at baseline and every year for a patient-average follow-up of 3 years. Subjects with CHF are divided into two groups: patients with one or no anabolic deficiency, and patients with two or more anabolic deficiencies at baseline. The primary endpoint is the composite of all-cause mortality and cardiovascular hospitalization. Secondary endpoints include the composite of all-cause mortality and hospitalization, the composite of cardiovascular mortality and cardiovascular hospitalization, and change of VO2 peak. Patient enrollment started in April 2013, and was completed in July 2017. Demographics and main clinical characteristics of enrolled patients are provided in this article. Detailed cross-sectional results will be available in late 2018. The T.O.S.CA. Registry represents the most robust prospective observational trial on MHDS in the field of CHF. The study findings will advance our knowledge with regard to the intimate mechanisms of CHF progression and hopefully pave the way for future randomized clinical trials of single or multiple hormonal replacement therapies in CHF.
2018
13
661
671
Bossone, E.; Arcopinto, M.; Iacoviello, M.; Triggiani, V.; Cacciatore, F.; Maiello, C.; Limongelli, G.; Masarone, D.; Perticone, F.; Sciacqua, A.; Perrone-Filardi, P.; Mancini, A.; Volterrani, M.; Vriz, O.; Castello, R.; Passantino, A.; Campo, M.; Modesti, P.A.; De Giorgi, A.; Monte, I.; Puzzo, A.; Ballotta, A.; Caliendo, L.; D’Assante, R.; Marra, A.M.; Salzano, A.; Suzuki, T.; Cittadini, A.; Saccà, L.; Monti, M.G.; Napoli, R.; Matarazzo, M.; Stagnaro, F.M.; Schiavo, A.; Valente, P.; Ferrara, F.; Russo, V.; Malinconico, M.; Citro, R.; Guastalamacchia, E.; Leone, M.; Amarelli, C.; Mattucci, I.; Calabrò, P.; Calabrò, R.; D’Andrea, A.; Maddaloni, V.; Pacileo, G.; Scarafile, R.; Belfiore, A.; Cimellaro, A.; Perrone Filardi, P.; Casaretti, L.; Paolillo, S.; Gargiulo, P.; Favuzzi, A.M.R.; Di Segni, C.; Bruno, C.; Vergani, E.; Massaro, R.; Grimaldi, F.; Frigo, A.; Sorrentino, M.R.; Malandrino, D.; Manfredini, R.; De Giorgi, A.; Fabbian, F.; Ragusa, L.; Carbone, L.; Frigiola, A.; Generali, T.; Giacomazzi, F.; De Vincentiis, C.; Garofalo, P.; Malizia, G.; Milano, S.; Misiano, G.; Heaney, L.M.; Bruzzese, D.
File in questo prodotto:
File Dimensione Formato  
2018 - Bossone2018_Article_MultipleHormonalAndMetabolicDe.pdf

Accesso chiuso

Descrizione: chronic heart failure
Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: DRM non definito
Dimensione 2.27 MB
Formato Adobe PDF
2.27 MB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1144446
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 43
social impact